Zofran Lawsuit Alleges Drug Caused Atrial Septal Defect In Infant Girl

November 10, 2015 – – ZofranLegal.com reports on another lawsuit filed against anti-nausea drug Zofran, alleging that exposure to the drug in utero caused an infant girl to develop a large atrial septal defect in her heart. The suit indicates that the child had to undergo open heart surgery when only three years old. The details involved in this suit are similar to those seen in many that have been filed across the nation, which allege that when a developing fetus is exposed to the drug, they may be at increased risk to develop birth defects. Defects most commonly named are cleft lip and palate, atrial septal defect, ventricular septal defect, transposition of the greater vessels, tetralogy of fallot, and clubfoot.

In this particular case, the girl’s mother, an Ohio resident, filed suit. The complaint was registered with the U.S. District Court for the Northern District of Ohio, Eastern Division under number 1:15-cv-01435. It is dated July 20th, 2015.

Like many other expectant mothers, the woman was prescribed Zofran “off-label” to treat her morning sickness, though the pill was not FDA approved for this use. The FDA approved the drug to treat those battling nausea associated with chemotherapy, radiation, and anesthesia. It was never tested for safety on pregnant women. Despite this fact, manufacturer GlaxoSmithKline marketed the drug to Ob/Gyns across the nation, and the drug is prescribed “off-label” to as many as 1 million pregnant women nationwide.

After being exposed to Zofran while her heart was doing much of its developing, the plaintiff’s daughter was born with a large defect. She spent more than a week in the NICU, and suffered subsequent breathing issues, even years after her open heart surgery. The hole in her heart created by the atrial septal defect mixes her oxygen rich blood with her oxygen poor blood, creating this problem.

As lawsuits similar to this one continue to be filed, studies have also emerged which seem to support their allegations. The attorneys at Monheit Law are currently working to help anyone who used Zofran during their pregnancy and has then given birth to a child with defects. These individuals may be entitled to compensation, and are able to explore their legal rights for free with Monheit Law.

For additional information on this topic, details of currently filed lawsuits, or to ask questions, please contact Michael Monheit, Esq. by calling 877-620-8411.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60005272